A study reported that JNK was significantly activated after cerebral ischemia/reperfusion injury in aged rats, while edaravone (3 mg/kg, i.v.)treatment significantly inhibited oxidative stress and the JNK signaling pathway [35]. The gene discussed is MAPK8; the disease is Cerebral ischemia.